Wise, Sarah K;
Damask, Cecelia;
Roland, Lauren T;
Ebert, Charles;
Levy, Joshua M;
Lin, Sandra;
Luong, Amber;
... Zhang, Luo; + view all
(2023)
International consensus statement on allergy and rhinology: Allergic rhinitis-2023.
International Forum of Allergy & Rhinology
, 13
(4)
pp. 293-859.
10.1002/alr.23090.
Preview |
PDF
International consensus statement on allergy and rhinology.pdf - Published Version Download (10MB) | Preview |
Abstract
Background: In the 5 years that have passed since the publication of the 2018 International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR-Allergic Rhinitis 2018), the literature has expanded substantially. The ICAR-Allergic Rhinitis 2023 update presents 144 individual topics on allergic rhinitis (AR), expanded by over 40 topics from the 2018 document. Originally presented topics from 2018 have also been reviewed and updated. The executive summary highlights key evidence-based findings and recommendation from the full document. Methods: ICAR-Allergic Rhinitis 2023 employed established evidence-based review with recommendation (EBRR) methodology to individually evaluate each topic. Stepwise iterative peer review and consensus was performed for each topic. The final document was then collated and includes the results of this work. Results: ICAR-Allergic Rhinitis 2023 includes 10 major content areas and 144 individual topics related to AR. For a substantial proportion of topics included, an aggregate grade of evidence is presented, which is determined by collating the levels of evidence for each available study identified in the literature. For topics in which a diagnostic or therapeutic intervention is considered, a recommendation summary is presented, which considers the aggregate grade of evidence, benefit, harm, and cost. Conclusion: The ICAR-Allergic Rhinitis 2023 update provides a comprehensive evaluation of AR and the currently available evidence. It is this evidence that contributes to our current knowledge base and recommendations for patient evaluation and treatment.
| Type: | Article |
|---|---|
| Title: | International consensus statement on allergy and rhinology: Allergic rhinitis-2023 |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1002/alr.23090 |
| Publisher version: | https://doi.org/10.1002/alr.23090 |
| Language: | English |
| Additional information: | © 2023 The Authors. International Forum of Allergy & Rhinology published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngic Allergy and American Rhinologic Society. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
| Keywords: | Science & Technology, Life Sciences & Biomedicine, Otorhinolaryngology, allergen extract, allergen immunotherapy, allergy, allergic rhinitis, antihistamine, asthma, atopic dermatitis, avoidance, biologic, cockroach, conjunctivitis, consensus, corticosteroid, cough, cromolyn, decongestant, eosinophilic esophagitis, environment, epicutaneous, immunotherapy, epidemiology, evidence-based medicine, food allergy, house dust mite, IgE, immunoglobulin E, inhalant allergy, leukotriene, microbiome, occupational rhinitis, omalizumab, pediatric, perennial, pet dander, pollen, probiotic, rhinitis, rhinosinusitis, saline, seasonal, sensitization, sinusitis, socioeconomic, specific IgE, subcutaneous immunotherapy, sublingual immunotherapy, systematic review, total IgE, transcutaneous immunotherapy, validated survey, QUALITY-OF-LIFE, HOUSE-DUST-MITE, AZELASTINE NASAL SPRAY, EXHALED NITRIC-OXIDE, OBSTRUCTIVE SLEEP-APNEA, PLACEBO-CONTROLLED TRIAL, SKIN-PRICK TEST, RANDOMIZED DOUBLE-BLIND, GRASS-POLLEN IMMUNOTHERAPY, ENVIRONMENTAL EXPOSURE UNIT |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci > Department of Targeted Intervention |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10179237 |
Archive Staff Only
 |
View Item |
